Phase III Trial of Immunotherapy with Recombinant Interleukin-2 (rIL-2) Versus Observation in Patients < 60 Years with Acute Myeloid Leukemia (AML) in First Remission (CR1): Preliminary Results from Cancer and Leukemia Group B (CALGB) 19808
- Citation:
- Blood vol 110 (11) 157
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Preliminary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 262
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- J. E. Kolitz V. Hars D. J. Deangelo S. L. Allen T. C. Shea R. Vij E. Hoke C. D. Bloomfield M. A. Caligiuri S. L. George R. A. Larson
- Networks:
- Study
- Multiple Studies, or Legacy Studies in Alliance Study:
- CALGB-19808, CALGB-8461, CALGB-9665
- Phases:
- 3, N/A
- Keywords: